Clinical trial
Diagnosis of Demodex Blapharitis and Treatment With Ivermectin Gel 0.1%/ Metronidazole 1%
NCT02236403 is registered in ClinicalTrials.gov with Universidad Nacional de Colombia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnosis of Demodex Blapharitis and Treatment With Ivermectin Gel 0.1%/ Metronidazole 1%
- Lead sponsor
- Universidad Nacional de Colombia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- January 31, 2015
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic blepharitis